FI955180A0 - Naftaleenifosfonihappojen ureidojohdannaiset ja menetelmä niiden valmistamiseksi - Google Patents

Naftaleenifosfonihappojen ureidojohdannaiset ja menetelmä niiden valmistamiseksi

Info

Publication number
FI955180A0
FI955180A0 FI955180A FI955180A FI955180A0 FI 955180 A0 FI955180 A0 FI 955180A0 FI 955180 A FI955180 A FI 955180A FI 955180 A FI955180 A FI 955180A FI 955180 A0 FI955180 A0 FI 955180A0
Authority
FI
Finland
Prior art keywords
pct
preparation
same
phosphonic acids
urea derivatives
Prior art date
Application number
FI955180A
Other languages
English (en)
Swedish (sv)
Other versions
FI955180A (fi
Inventor
Nicola Mongelli
Angelo Grugnola
Borgia Andrea Lombardi
Enrico Presenti
Original Assignee
Pharmacia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Spa filed Critical Pharmacia Spa
Publication of FI955180A publication Critical patent/FI955180A/fi
Publication of FI955180A0 publication Critical patent/FI955180A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • AIDS & HIV (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
  • Luminescent Compositions (AREA)
FI955180A 1994-03-01 1995-10-30 Naftaleenifosfonihappojen ureidojohdannaiset ja menetelmä niiden valmistamiseksi FI955180A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9403909A GB9403909D0 (en) 1994-03-01 1994-03-01 Ureido derivatives of naphthalenephosphonic acids and process for their preparation
PCT/EP1995/000444 WO1995023806A2 (en) 1994-03-01 1995-02-08 Ureido derivatives of naphthalenephosphonic acids and process for their preparation

Publications (2)

Publication Number Publication Date
FI955180A FI955180A (fi) 1995-10-30
FI955180A0 true FI955180A0 (fi) 1995-10-30

Family

ID=10751089

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955180A FI955180A0 (fi) 1994-03-01 1995-10-30 Naftaleenifosfonihappojen ureidojohdannaiset ja menetelmä niiden valmistamiseksi

Country Status (26)

Country Link
US (1) US5700788A (fi)
EP (1) EP0696287B1 (fi)
JP (1) JPH08509992A (fi)
KR (1) KR960701881A (fi)
CN (1) CN1061050C (fi)
AT (1) ATE190312T1 (fi)
AU (1) AU678704B2 (fi)
CA (1) CA2160250A1 (fi)
DE (1) DE69515390T2 (fi)
DK (1) DK0696287T3 (fi)
ES (1) ES2145268T3 (fi)
FI (1) FI955180A0 (fi)
GB (1) GB9403909D0 (fi)
GR (1) GR3033356T3 (fi)
HU (1) HUT74987A (fi)
IL (1) IL112716A0 (fi)
MX (1) MX9504381A (fi)
MY (1) MY130125A (fi)
NO (1) NO308005B1 (fi)
NZ (1) NZ281205A (fi)
PL (1) PL311339A1 (fi)
PT (1) PT696287E (fi)
RU (1) RU2136692C1 (fi)
TW (1) TW290547B (fi)
WO (1) WO1995023806A2 (fi)
ZA (1) ZA951653B (fi)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5959087A (en) * 1989-08-07 1999-09-28 Peptide Technology, Ltd. Tumour necrosis factor binding ligands
DE69027121T3 (de) * 1989-08-07 2001-08-30 Peptech Ltd., Dee Why Bindeligande für tumornekrosisfaktor
US20030225254A1 (en) * 1989-08-07 2003-12-04 Rathjen Deborah Ann Tumour necrosis factor binding ligands
US6284471B1 (en) * 1991-03-18 2001-09-04 New York University Medical Center Anti-TNFa antibodies and assays employing anti-TNFa antibodies
US7192584B2 (en) 1991-03-18 2007-03-20 Centocor, Inc. Methods of treating psoriasis with anti-TNF antibodies
US20040120952A1 (en) * 2000-08-07 2004-06-24 Centocor, Inc Anti-TNF antibodies and peptides of human tumor necrosis factor
US6277969B1 (en) * 1991-03-18 2001-08-21 New York University Anti-TNF antibodies and peptides of human tumor necrosis factor
US20050260201A1 (en) * 1993-01-29 2005-11-24 Centocor, Inc. Methods of treating rheumatoid arthritis using anti-TNF receptor fusion proteins
GB9504065D0 (en) * 1995-03-01 1995-04-19 Pharmacia Spa Poly-pyrrolecarboxamidonaphthalenic acid derivatives
FR2736914B1 (fr) * 1995-07-21 1997-08-22 Adir Nouveaux derives d'acide aminophenylphosphonique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB2310207A (en) * 1996-02-15 1997-08-20 Pharmacia Spa Antiviral ureido derivatives of substituted heterocyclic compounds
FR2758560B1 (fr) * 1997-01-20 2000-02-04 Adir Nouveaux derives d'acides aminophenylboronique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2758562B1 (fr) * 1997-01-20 1999-02-19 Adir Nouveaux derives d'acides mixtes aminobenzyliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB9713733D0 (en) * 1997-06-27 1997-09-03 Pharmacia & Upjohn Spa Poly-branched polycarboxamido compounds
GB9713732D0 (en) * 1997-06-27 1997-09-03 Pharmacia & Upjohn Spa Substituted triazinic compounds
US6096730A (en) * 1997-07-24 2000-08-01 University Of Kentucky Research Foundation Phosphonated agents and their antiangiogenic and antitumorigenic use
AU739637B2 (en) * 1997-07-24 2001-10-18 University Of Kentucky Research Foundation, The Phosphonated agents and their antiangiogenic and antitumorigenic use
US6562859B1 (en) 1997-12-04 2003-05-13 The United States Of America As Represented By The Department Of Health And Human Services Ureido derivatives of poly-4-amino-2-carboxy-1-methyl pyrrole compounds for inhibition of inflammation
US6458775B1 (en) 1998-07-06 2002-10-01 Guilford Pharmaceutical Inc. NAALADase inhibitors useful as pharmaceutical compounds and compositions
US6395718B1 (en) 1998-07-06 2002-05-28 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of inhibiting angiogenesis using naaladase inhibitors
DE60045240D1 (de) * 1999-03-02 2010-12-30 Centocor Inc Antikörper gegen tnf alpha zur therapie von steroidresistentem asthma
US6348464B1 (en) 1999-11-12 2002-02-19 Guilford Pharmaceuticals, Inc. Pyrrolecarbonylimino derivatives as naaladase inhibitors
US20050249735A1 (en) * 2000-08-07 2005-11-10 Centocor, Inc. Methods of treating ankylosing spondylitis using anti-TNF antibodies and peptides of human tumor necrosis factor
US20060018907A1 (en) * 2000-08-07 2006-01-26 Centocor, Inc. Anti-TNF antibodies and peptides of human tumor necrosis factor
US20110195063A1 (en) * 2000-08-07 2011-08-11 Centocor, Inc. Methods of Treating Ankylosing Spondylitis Using Anti-TNF Antibodies and Peptides of Human Tumor Necrosis Factor
TWI327597B (en) * 2001-08-01 2010-07-21 Centocor Inc Anti-tnf antibodies, compositions, methods and uses
US20090038182A1 (en) * 2007-08-09 2009-02-12 Lans Maris J Footwear with built-in scale
US10465003B2 (en) 2016-02-05 2019-11-05 Janssen Biotech, Inc. Anti-TNF antibodies, compositions, methods and use for the treatment or prevention of type 1 diabetes
EP3381897A1 (en) 2017-03-27 2018-10-03 Leadiant Biosciences SA Derivatives of the disodium 2,2'-{carbonylbis[imino-3,1-phenylenecarbonylimino(1-methyl-1h-pyrrole-4,2-diyl)carbonylimino]}dinaphthalene-1,5-disulfonate salt and related compounds as heparanase inhibitors for the treatment of cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5310752A (en) * 1986-05-20 1994-05-10 Farmitalia Carlo Erba Spa Site specific alkylating agents
CA1308516C (en) * 1987-07-06 1992-10-06 J. William Lown Oligopeptide anticancer and antiviral agents
GB9000644D0 (en) * 1990-01-11 1990-03-14 Erba Carlo Spa New ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds
IT1247878B (it) * 1991-02-15 1995-01-05 Menarini Farma Ind Derivati poli-4-aminopirrol-2-carbossiamidici,processi di preparazione e composizioni farmaceutiche che li contengono
GB9304589D0 (en) * 1993-03-05 1993-04-21 Erba Carlo Spa Biologically active ureido derivatives useful as antimetastic agents

Also Published As

Publication number Publication date
NZ281205A (en) 1997-01-29
AU678704B2 (en) 1997-06-05
HUT74987A (en) 1997-03-28
ATE190312T1 (de) 2000-03-15
FI955180A (fi) 1995-10-30
DE69515390D1 (de) 2000-04-13
EP0696287B1 (en) 2000-03-08
MX9504381A (es) 1997-01-31
WO1995023806A3 (en) 1995-09-28
US5700788A (en) 1997-12-23
DK0696287T3 (da) 2000-07-31
HU9503433D0 (en) 1996-01-29
PT696287E (pt) 2000-08-31
DE69515390T2 (de) 2000-09-21
GB9403909D0 (en) 1994-04-20
CN1061050C (zh) 2001-01-24
IL112716A0 (en) 1995-05-26
EP0696287A1 (en) 1996-02-14
NO308005B1 (no) 2000-07-03
CA2160250A1 (en) 1995-09-08
MY130125A (en) 2007-06-29
GR3033356T3 (en) 2000-09-29
CN1124027A (zh) 1996-06-05
RU2136692C1 (ru) 1999-09-10
NO954346D0 (no) 1995-10-30
TW290547B (fi) 1996-11-11
PL311339A1 (en) 1996-02-05
WO1995023806A2 (en) 1995-09-08
NO954346L (no) 1995-10-30
ZA951653B (en) 1995-12-08
KR960701881A (ko) 1996-03-28
AU1848895A (en) 1995-09-18
JPH08509992A (ja) 1996-10-22
ES2145268T3 (es) 2000-07-01

Similar Documents

Publication Publication Date Title
FI955180A0 (fi) Naftaleenifosfonihappojen ureidojohdannaiset ja menetelmä niiden valmistamiseksi
DE69305322D1 (de) Salpetersäureester von 2-(2,6-dihalophenylamino)phenylessigsäurederivaten und verfahren zu ihrer herstellung
FI954898A0 (fi) Vesiliukoiset kamptotesiinijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö kasvaintenvastaisina aineina
HUT74429A (en) Cyclic polyamines, process for producing them and pharmaceutical compositions containing the same
PL310398A1 (en) Novel compounds
FI963440A0 (fi) Uudet aminohappojohdannaiset, näiden valmistusmenetelmä ja näitä yhdisteitä sisältävät farmaseuttiset seokset
NO981970D0 (no) FremgangsmÕte for fremstilling av Camptothecin-derivater
CA2127067A1 (fr) Derives d'acide phosphonique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MX9306421A (es) Derivados de amidas y procedimiento para su preparacion.
EA199700302A1 (ru) Биологически активные уреидо-производные, полезные при лечении рассеянного склероза
GB9806358D0 (en) Synthesis of carboxylic acid derivatives
SE9203824L (sv) Bensofuranylimidazol-derivat, foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande desamma
FI955282A (fi) Menetelmä NG-monoalkyyli-L-arginiinin ja vastaavien yhdisteiden valmistamiseksi
ES2105312T3 (es) Procedimiento quimico de preparacion de un aminodiol opticamente activo.
HUP9902307A2 (hu) Új, áthidalt gyűrűs aminosavak, előállításuk és intermedierjeik

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: PHARMACIA & UPJOHN S.P.A.